# AbbVie (ABBV) SEC filings: latest 10-K, 10-Q and 8-K

URL: https://funkfolio.com/stock/ABBV/filings

> AbbVie (ABBV) SEC filings from EDGAR: 10-K filed Feb 20, 2026, 10-Q filed Nov 3, 2026, 8-K filed Nov 2, 2026. 88 filings in the last 12 months.

---

## AbbVie (ABBV) SEC filings

AbbVie's latest annual report is a Form 10-K filed on February 20, 2026 for the period ended December 31, 2025. Its latest quarterly report, a Form 10-Q, was filed on November 3, 2026. Its latest current report, a Form 8-K, was filed on November 2, 2026. EDGAR lists 88 filings for it in the last twelve months.

### Key facts

- **Latest annual report:** 10-K, Feb 20, 2026
- **Latest quarterly report:** 10-Q, Nov 3, 2026
- **Latest 8-K:** 8-K, Nov 2, 2026
- **Filings, last 12 months:** 88
- **Insider forms, last 12 months:** 45 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 2
- **SEC central index key:** 0001551152

Filings as listed by SEC EDGAR at Nov 18, 2026, 10:21 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0001551152](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001551152). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

AbbVie: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/abbv-20260930.htm) | Nov 3, 2026 | Sep 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm) | Aug 3, 2026 | Jun 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000017/abbv-20260331.htm) | May 8, 2026 | Mar 31, 2026 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/abbv-20251231.htm) | Feb 20, 2026 | Dec 31, 2025 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/abbv-20250930.htm) | Nov 4, 2025 | Sep 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115225000040/abbv-20250630.htm) | Aug 4, 2025 | Jun 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115225000029/abbv-20250331.htm) | May 9, 2025 | Mar 31, 2025 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm) | Feb 14, 2025 | Dec 31, 2024 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115224000040/abbv-20240930.htm) | Nov 4, 2024 | Sep 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115224000031/abbv-20240630.htm) | Aug 7, 2024 | Jun 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115224000020/abbv-20240331.htm) | May 3, 2024 | Mar 31, 2024 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/abbv-20231231.htm) | Feb 20, 2024 | Dec 31, 2023 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/abbv-20230930.htm) | Nov 6, 2023 | Sep 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115223000033/abbv-20230630.htm) | Aug 7, 2023 | Jun 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/abbv-20230331.htm) | May 5, 2023 | Mar 31, 2023 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/abbv-20221231.htm) | Feb 17, 2023 | Dec 31, 2022 | Annual report |

The latest 16 of 38 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

### Current reports (8-K)

AbbVie: current reports on Form 8-K and the items each reports

| Form | Filed | Event date | What it reports |
| --- | --- | --- | --- |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926121322/tm2628215d1_8k.htm) | Nov 2, 2026 | Oct 28, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000033/abbv-20261030.htm) | Oct 30, 2026 | Oct 30, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926116227/tm2627361d1_8k.htm) | Oct 15, 2026 | Oct 14, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000030/abbv-20261005.htm) | Oct 5, 2026 | Oct 5, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k.htm) | Sep 3, 2026 | Sep 3, 2026 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926098367/tm2623337d1_8k.htm) | Aug 18, 2026 | Aug 18, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926091269/tm2621452d4_8k.htm) | Aug 5, 2026 | Aug 4, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000023/abbv-20260731.htm) | Jul 31, 2026 | Jul 31, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000021/abbv-20260706.htm) | Jul 6, 2026 | Jul 6, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926076067/tm2618365d1_8k.htm) | Jun 22, 2026 | Jun 18, 2026 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926059484/tm2614276d1_8k.htm) | May 12, 2026 | May 8, 2026 | 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000013/abbv-20260429.htm) | Apr 29, 2026 | Apr 29, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000011/abbv-20260403.htm) | Apr 3, 2026 | Apr 3, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926023534/tm266774d4_8k.htm) | Mar 4, 2026 | Mar 4, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926020643/tm266774d4_8k.htm) | Feb 26, 2026 | Feb 24, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000004/abbv-20260204.htm) | Feb 4, 2026 | Feb 4, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000002/abbv-20260107.htm) | Jan 7, 2026 | Jan 7, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115225000047/abbv-20251031.htm) | Oct 31, 2025 | Oct 31, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000155115225000043/abbv-20251003.htm) | Oct 3, 2025 | Oct 3, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465925089245/tm2525781d1_8k.htm) | Sep 11, 2025 | Sep 11, 2025 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |

The latest 20 of 148 in EDGAR's recent list. Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

### Insider forms (3, 4 and 5)

AbbVie: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 1 |
| Oct 2026 | 3 |
| Sep 2026 | 0 |
| Aug 2026 | 1 |
| Jul 2026 | 2 |
| Jun 2026 | 0 |
| May 2026 | 11 |
| Apr 2026 | 3 |
| Mar 2026 | 11 |
| Feb 2026 | 10 |
| Jan 2026 | 3 |
| Dec 2025 | 0 |

AbbVie: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000176167526000007/xslF345X06/form4-11122026_051120.xml) | Nov 12, 2026 | Nov 9, 2026 |
| [3](https://www.sec.gov/Archives/edgar/data/1551152/000187460426000003/xslF345X06/form3-10232026_091038.xml) | Oct 23, 2026 | Oct 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000199750526000010/xslF345X06/form4-10022026_051005.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000117178026000014/xslF345X06/form4-10022026_051002.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000176295126000006/xslF345X06/form4-08182026_050811.xml) | Aug 18, 2026 | Aug 14, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000117178026000012/xslF345X06/form4-07022026_050703.xml) | Jul 2, 2026 | Jul 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000199750526000008/xslF345X06/form4-07022026_050702.xml) | Jul 2, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000122289026000003/xslF345X06/form4-05122026_050524.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000122369026000004/xslF345X06/form4-05122026_050522.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000135558026000002/xslF345X06/form4-05122026_050520.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000117178026000010/xslF345X06/form4-05122026_050518.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000199750526000006/xslF345X06/form4-05122026_050515.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000170612626000002/xslF345X06/form4-05122026_050513.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000146633826000003/xslF345X06/form4-05122026_050511.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000123912626000002/xslF345X06/form4-05122026_050509.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000191666526000002/xslF345X06/form4-05122026_050507.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000156357926000002/xslF345X06/form4-05122026_050505.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000106163226000004/xslF345X06/form4-05122026_050501.xml) | May 12, 2026 | May 8, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000199750526000004/xslF345X06/form4-04022026_050411.xml) | Apr 2, 2026 | Mar 31, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1551152/000117178026000006/xslF345X06/form4-04022026_050408.xml) | Apr 2, 2026 | Mar 31, 2026 |

The latest 20 of 604 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

AbbVie: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1551152/000210011926000126/xslSCHEDULE_13G_X02/primary_doc.xml) | Apr 29, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000010290926000503/xslSCHEDULE_13G_X02/primary_doc.xml) | Mar 26, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000093247125000695/xslSCHEDULE_13G_X01/primary_doc.xml) | Jul 7, 2025 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1551152/000110465925014772/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 18, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000110465924020157/tv0164-abbvieinc.htm) | Feb 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000108636424003786/us00287y1091_012524.txt) | Jan 25, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000130655023008705/us00287y1091_021523.txt) | Feb 16, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000110465923015040/tv0002-abbvieinc.htm) | Feb 9, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000110465922016352/tv0138-abbvieinc.htm) | Feb 9, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000083423722006222/us00287y1091_020322.txt) | Feb 3, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000142284821000091/SEC13G_Filing.htm) | Feb 16, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000110465921017320/tv0110-abbvieinc.htm) | Feb 10, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000083423721003108/us00287y1091_012821.txt) | Jan 29, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000142284820000004/edgabbv.txt) | Feb 14, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000110465920018275/tv01572-abbvieinc.htm) | Feb 12, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000083423720004893/us00287y1091_020420.txt) | Feb 5, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000142284819000141/edgarABBV.txt) | Nov 8, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000093247119006222/abbvieinc.htm) | Feb 14, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000142284819000006/edgabbv.txt) | Feb 14, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000093247119004202/dummydocument.htm) | Feb 11, 2019 | — |

The latest 20 of 27 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

### Proxy statements

AbbVie: proxy statements and proxy materials

| Form | Filed | Meeting or period | Document |
| --- | --- | --- | --- |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000110465926033391/abbv-20260323xdefa14a.htm) | Mar 23, 2026 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1551152/000110465926033387/abbv-20260508xdef14a.htm) | Mar 23, 2026 | May 8, 2026 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1551152/000110465926025260/abbv-20260309xpre14a.htm) | Mar 9, 2026 | Mar 9, 2026 | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837025003538/tmb-20250324xdefa14a.htm) | Mar 24, 2025 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837025003537/abbv-20250509xdef14a.htm) | Mar 24, 2025 | May 9, 2025 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837025002603/abbv-20250509xpre14a.htm) | Mar 10, 2025 | May 9, 2025 | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837024003498/tmb-20240318xdefa14a.htm) | Mar 18, 2024 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837024003496/abbv-20240503xdef14a.htm) | Mar 18, 2024 | May 3, 2024 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837024002359/abbv-20240503xpre14a.htm) | Mar 4, 2024 | May 3, 2024 | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000110465923037696/tm2310745d1_defa14a.htm) | Mar 28, 2023 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000110465923035159/tm233485d3_defa14a.htm) | Mar 21, 2023 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837023004206/tmb-20230320xdefa14a.htm) | Mar 20, 2023 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837023004204/abbv-20230505xdef14a.htm) | Mar 20, 2023 | — | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837023002939/abbv-20230505xpre14a.htm) | Mar 6, 2023 | — | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837022004013/tmb-20220321xdefa14a.htm) | Mar 21, 2022 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837022004011/tmb-20220506xdef14a.htm) | Mar 21, 2022 | May 6, 2022 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837022002961/tmb-20220506xpre14a.htm) | Mar 7, 2022 | May 6, 2022 | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837021003321/tmb-20210322xdefa14a.htm) | Mar 22, 2021 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837021003318/tmb-20210507xdef14a.htm) | Mar 22, 2021 | May 7, 2021 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1551152/000155837021002580/tmb-20210507xpre14a.htm) | Mar 8, 2021 | May 7, 2021 | Preliminary proxy statement |

The latest 20 of 29 in EDGAR's recent list.

**Everything else (163 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

AbbVie: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004726011127/xsl144X01/primary_doc.xml) | Nov 16, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004726010822/xsl144X01/primary_doc.xml) | Nov 9, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004726008158/xsl144X01/primary_doc.xml) | Aug 14, 2026 | — | Notice of proposed sale |
| [424B5](https://www.sec.gov/Archives/edgar/data/1551152/000110465926092114/tm2621452-3_424b5.htm) | Aug 6, 2026 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1551152/000110465926090611/tm2621452d2_fwp.htm) | Aug 5, 2026 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1551152/000110465926090092/tm2621452-1_424b5.htm) | Aug 4, 2026 | — | Prospectus |
| [11-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465926077366/abbv-20251231x11k.htm) | Jun 24, 2026 | Dec 31, 2025 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/1551152/000110465926069017/tm2615651d2_sd.htm) | Jun 1, 2026 | — | FORM SD |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004726005041/xsl144X01/primary_doc.xml) | May 26, 2026 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/1551152/000110465926033397/tm2532582d2_ars.pdf) | Mar 23, 2026 | Dec 31, 2025 |  |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000205769626000007/xsl144X01/primary_doc.xml) | Mar 6, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004726001937/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [424B5](https://www.sec.gov/Archives/edgar/data/1551152/000110465926020619/tm266774-2_424b5.htm) | Feb 26, 2026 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1551152/000110465926020557/tm266774d5_fwp.htm) | Feb 26, 2026 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004726001796/xsl144X01/primary_doc.xml) | Feb 25, 2026 | — | Notice of proposed sale |
| [FWP](https://www.sec.gov/Archives/edgar/data/1551152/000110465926019303/tm266774d3_fwp.htm) | Feb 25, 2026 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1551152/000110465926018861/tm266774-1_424b5.htm) | Feb 24, 2026 | — | Prospectus |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000141588925022795/xsl144X01/primary_doc.xml) | Aug 22, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000141588925022645/xsl144X01/primary_doc.xml) | Aug 21, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725005725/xsl144X01/primary_doc.xml) | Aug 12, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000141588925021352/xsl144X01/primary_doc.xml) | Aug 8, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725005455/xsl144X01/primary_doc.xml) | Aug 5, 2025 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465925059360/tm2517646d1_11k.htm) | Jun 13, 2025 | Dec 31, 2024 | FORM 11-K |
| [SD](https://www.sec.gov/Archives/edgar/data/1551152/000110465925054864/tm2515986d1_sd.htm) | May 30, 2025 | — | FORM SD |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236225000336/xsl144X01/primary_doc.xml) | Mar 31, 2025 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/1551152/000110465925027375/tm252086d2_ars.pdf) | Mar 25, 2025 | Dec 31, 2024 |  |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236225000309/xsl144X01/primary_doc.xml) | Mar 14, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236225000217/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725001432/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725001366/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236225000201/xsl144X01/primary_doc.xml) | Feb 28, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725001341/xsl144X01/primary_doc.xml) | Feb 28, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236225000186/xsl144X01/primary_doc.xml) | Feb 26, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725001261/xsl144X01/primary_doc.xml) | Feb 26, 2025 | — | Notice of proposed sale |
| [424B5](https://www.sec.gov/Archives/edgar/data/1551152/000110465925015715/tm255723-6_424b5.htm) | Feb 20, 2025 | — | Prospectus |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004725001078/xsl144X01/primary_doc.xml) | Feb 20, 2025 | — | Notice of proposed sale |
| [FWP](https://www.sec.gov/Archives/edgar/data/1551152/000110465925014903/tm255723d5_fwp.htm) | Feb 19, 2025 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/1551152/000110465925014554/tm255723-3_424b5.htm) | Feb 18, 2025 | — | Prospectus |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/1551152/000110465925014191/tm255723-1_s3asr.htm) | Feb 14, 2025 | — | Short-form registration statement |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224001885/xsl144X01/primary_doc.xml) | Dec 16, 2024 | — | Notice of proposed sale |
| [S-8](https://www.sec.gov/Archives/edgar/data/1551152/000110465924113907/tm2427253d2_s8.htm) | Nov 4, 2024 | — | Registration statement for employee plans |
| [S-8](https://www.sec.gov/Archives/edgar/data/1551152/000110465924113897/tm2427253d1_s8.htm) | Nov 4, 2024 | — | FORM S-8 |
| [S-8](https://www.sec.gov/Archives/edgar/data/1551152/000110465924089617/tm2420586d1_s8.htm) | Aug 14, 2024 | — | FORM S-8 |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224001096/xsl144X01/primary_doc.xml) | Aug 8, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224001083/xsl144X01/primary_doc.xml) | Aug 7, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000194984624000432/xsl144X01/primary_doc.xml) | Aug 5, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004724005479/xsl144X01/primary_doc.xml) | Jul 17, 2024 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/1551152/000110465924075726/tm2418364d1_11k.htm) | Jun 27, 2024 | Dec 31, 2023 | FORM 11-K |
| [25-NSE](https://www.sec.gov/Archives/edgar/data/1551152/000087666124000445/xslF25X02/primary_doc.xml) | Jun 3, 2024 | — |  |
| [SD](https://www.sec.gov/Archives/edgar/data/1551152/000110465924067135/tm2415825d1_sd.htm) | May 31, 2024 | — | FORM SD |
| [25-NSE](https://www.sec.gov/Archives/edgar/data/1551152/000087666124000360/xslF25X02/primary_doc.xml) | May 17, 2024 | — |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/1551152/000121465924005805/p41245px14a6g.htm) | Apr 2, 2024 | — |  |
| [PX14A6G](https://www.sec.gov/Archives/edgar/data/1551152/000121465924005132/b326242px14a6g.htm) | Mar 26, 2024 | — |  |
| [144 (amended)](https://www.sec.gov/Archives/edgar/data/1551152/000197236224000449/xsl144X01/primary_doc.xml) | Mar 21, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224000448/xsl144X01/primary_doc.xml) | Mar 20, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224000439/xsl144X01/primary_doc.xml) | Mar 18, 2024 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/1551152/000110465924035573/tm244274d2_ars.pdf) | Mar 18, 2024 | Dec 31, 2023 |  |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224000282/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000195004724001638/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1551152/000197236224000264/xsl144X01/primary_doc.xml) | Feb 29, 2024 | — | Notice of proposed sale |

The latest 60 of 163 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Schedule 13D — Schedule 13D beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities; also used to disclose later changes to the holding.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form DEF 14A — Definitive proxy statement**

The final proxy statement sent to shareholders for a shareholder meeting: the matters to be voted on, and typically executive and board compensation and who owns more than five percent.

**Form PRE 14A — Preliminary proxy statement**

A preliminary proxy statement subject to review by the SEC staff.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form S-3 — Short-form registration statement**

An abbreviated registration statement available to certain already-reporting companies to register the offer and sale of securities to the public.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

**Form SD — Specialized disclosure report**

In the SEC's Forms Index: Specialized Disclosure Report.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is AbbVie's latest annual report (10-K)?**

AbbVie filed its latest Form 10-K with the SEC on February 20, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**When did AbbVie file its latest 10-Q?**

On November 3, 2026 for the period ended September 30, 2026. A Form 10-Q holds unaudited quarterly financial statements and management's discussion of the quarter.

**What has AbbVie reported on Form 8-K recently?**

Its latest 8-K was filed on November 2, 2026 (5.02 Departure or Election of Directors or Officers; Officer Compensation). In the last twelve months the items it reported most often were: 2.02 Results of Operations and Financial Condition (8 reports); 8.01 Other Events (4 reports); 5.02 Departure or Election of Directors or Officers; Officer Compensation (2 reports). An 8-K discloses material events before the next quarterly or annual report.

**How many insider filings (Forms 3, 4 and 5) were there for ABBV in the last year?**

45 insider forms in the twelve months to November 18, 2026, the latest a Form 4 filed on November 12, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of AbbVie?**

EDGAR lists 2 Schedule 13D or 13G filings about AbbVie in the last twelve months, the latest on April 29, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “AbbVie (ABBV) SEC filings: latest 10-K, 10-Q and 8-K”, data as of 18 November 2026. https://funkfolio.com/stock/ABBV/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
